مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

374
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

233
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

HUMAN MENOPAUSAL GONADOTROPIN VERSUS RECOMBINANT FSH IN POLYCYSTIC OVARY SYNDROME PATIENTS UNDERGOING IN VITRO FERTILIZATION

Pages

  238-243

Abstract

 Background: We aimed to compare human menopausal gonadotropin (HMG) and recombinant follicle-stimulating hormone (r FSH) with respect to clinical outcomes and the development of ovarian hyperstimulation syndrome (OHSS) for patients with POLYCYSTIC OVARY SYNDROME (PCOS) treated with IN VITRO FERTILIZATION (IVF).Materials and Methods: This prospective randomized controlled trial included a total of 80 women with PCOS. Of these, 38 were randomized to receive treatment with HMG and 42 with rFSH using a long gonadotropin releasing hormone (GnRH) analogue protocol. Outcome measures were cycle characteristics, pregnancy rates, the need for coasting, and OHSS rates.Results: In the HMG group we observed a significantly lower peak estradiol (E2)level (p=0.02), fewer intermediate-sized follicles (p=0.001), lower number of oocytes retrieved (p=0.002) and metaphase II (MII) oocytes (p=0.003). However, there were no significant differences between the groups in the number of fertilized oocytes, fertilization rates, top quality embryo counts, and the number of transferred embryos. There was no difference in pregnancy rates between the groups.OHSS occurred in 11.9% of the rFSH group patients, whereas no OHSS developed in the HMG group.Coasting requirements were lower in the HMG group (19.2% vs.48.9%, p=0.013).Conclusion: Ovarian stimulation with HMG and rFSH provides similar clinical pregnancy rates in PCOS patients treated with a long GnRH agonist protocol in IVF cycles. HMG stimulation appears to be associated with a lower rate of OHSS and decreased coasting requirements (Registration Number: NCT01365936).

Cites

  • No record.

    • References

    Cite

    APA: Copy

    FIGEN TURKCAPAR, AYSE, SECKIN, BERNA, ONALAN, GOGSEN, OZDENER, TULIN, & BATIOGLU, SERTAC. (2013). HUMAN MENOPAUSAL GONADOTROPIN VERSUS RECOMBINANT FSH IN POLYCYSTIC OVARY SYNDROME PATIENTS UNDERGOING IN VITRO FERTILIZATION. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, 6(4), 238-243. SID. https://sid.ir/paper/305387/en

    Vancouver: Copy

    FIGEN TURKCAPAR AYSE, SECKIN BERNA, ONALAN GOGSEN, OZDENER TULIN, BATIOGLU SERTAC. HUMAN MENOPAUSAL GONADOTROPIN VERSUS RECOMBINANT FSH IN POLYCYSTIC OVARY SYNDROME PATIENTS UNDERGOING IN VITRO FERTILIZATION. INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY[Internet]. 2013;6(4):238-243. Available from: https://sid.ir/paper/305387/en

    IEEE: Copy

    AYSE FIGEN TURKCAPAR, BERNA SECKIN, GOGSEN ONALAN, TULIN OZDENER, and SERTAC BATIOGLU, “HUMAN MENOPAUSAL GONADOTROPIN VERSUS RECOMBINANT FSH IN POLYCYSTIC OVARY SYNDROME PATIENTS UNDERGOING IN VITRO FERTILIZATION,” INTERNATIONAL JOURNAL OF FERTILITY AND STERILITY, vol. 6, no. 4, pp. 238–243, 2013, [Online]. Available: https://sid.ir/paper/305387/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button